麦澜德跌2.02%，成交额6039.33万元，主力资金净流出152.80万元

Core Viewpoint - 麦澜德's stock price has shown significant volatility, with a year-to-date increase of 77.07%, but recent declines in the short term raise questions about future performance [2][3]. Company Overview - 南京麦澜德医疗科技股份有限公司, established on January 16, 2013, and listed on August 11, 2022, specializes in the research, production, sales, and services of products related to pelvic floor and postpartum rehabilitation [2]. - The company's revenue composition includes pelvic rehabilitation products (36.98%), reproductive rehabilitation products (33.10%), consumables and accessories (24.32%), sports rehabilitation products (2.77%), and other products (2.84%) [2]. Financial Performance - For the first half of 2025, 麦澜德 reported revenue of 241 million yuan, a year-on-year increase of 5.62%, while net profit attributable to shareholders decreased by 11.96% to 63.92 million yuan [3]. - Since its A-share listing, 麦澜德 has distributed a total of 268 million yuan in dividends [4]. Shareholder and Market Activity - As of June 30, 2025, 麦澜德 had 5,461 shareholders, an increase of 10.84% from the previous period, with an average of 6,743 circulating shares per shareholder, down by 9.78% [3]. - The stock has experienced significant trading activity, with a recent net outflow of 1.528 million yuan in principal funds, indicating mixed investor sentiment [1][2].